AbstractMacrolide resistance among Streptococcus pyogenes (group A streptococci) in Portugal was stable during 1998–2003, but a rapid inversion in the dominant phenotypes was noted in the same period, with a sharp decrease in the proportion of isolates presenting the MLSB phenotype and a concomitant increase in isolates presenting the M phenotype. The characterization of group A streptococci recovered during 2004–2006, which is reported here, revealed that resistance was not stable during this period and that the decline in erythromycin resistance observed during 2004–2006 was due to a decrease in the prevalence of isolates presenting the M phenotype, while the proportion of isolates expressing the MLSB phenotype remained stable. Characteri...
coccus pyogenes), major causative agents of human disease (1), can produce both mild (e.g., pharyngi...
Streptococcal infections are usually treated with beta-lactam antibiotics, but, in case of allergic ...
ABSTRACTAn unusual emm53, T-28/T-non-typeable, iMLSB phenotype clone represented a substantial propo...
AbstractMacrolide resistance among Streptococcus pyogenes (group A streptococci) in Portugal was sta...
of macrolide resistance phenotypes and clonal composition of the population. The aims of this study ...
T12/emm22 MLSB isolates could partially explain the drop in this phenotype, but the rise of the M ph...
BACKGROUND: Group A Streptococcus (GAS) causes human diseases ranging in severity from uncomplicated...
Susceptibility to macrolides and lincosamides was investigated with 299 consecutive nonduplicate Str...
Objectives. Surveillance of antimicrobial resistance and global dissemination of clones with specifi...
One hundred and thirty seven consecutive clinical Streptococcus pyogenes isolates were evaluated for...
We evaluated temporal fluctuations in macrolide resistance rates, analysing genetic determinants of ...
Objectives: The aim of this study was to investigate Polish clinical isolates of Streptococcus pyoge...
The aim of this study was to determine whether the high levels of erythromycin resistance in Strepto...
Macrolide-resistance was assessed in 216 consecutive Streptococcus pyogenes isolates from throat inf...
Streptococcus pyogenes is responsible for a variety of infectious diseases and immunological complic...
coccus pyogenes), major causative agents of human disease (1), can produce both mild (e.g., pharyngi...
Streptococcal infections are usually treated with beta-lactam antibiotics, but, in case of allergic ...
ABSTRACTAn unusual emm53, T-28/T-non-typeable, iMLSB phenotype clone represented a substantial propo...
AbstractMacrolide resistance among Streptococcus pyogenes (group A streptococci) in Portugal was sta...
of macrolide resistance phenotypes and clonal composition of the population. The aims of this study ...
T12/emm22 MLSB isolates could partially explain the drop in this phenotype, but the rise of the M ph...
BACKGROUND: Group A Streptococcus (GAS) causes human diseases ranging in severity from uncomplicated...
Susceptibility to macrolides and lincosamides was investigated with 299 consecutive nonduplicate Str...
Objectives. Surveillance of antimicrobial resistance and global dissemination of clones with specifi...
One hundred and thirty seven consecutive clinical Streptococcus pyogenes isolates were evaluated for...
We evaluated temporal fluctuations in macrolide resistance rates, analysing genetic determinants of ...
Objectives: The aim of this study was to investigate Polish clinical isolates of Streptococcus pyoge...
The aim of this study was to determine whether the high levels of erythromycin resistance in Strepto...
Macrolide-resistance was assessed in 216 consecutive Streptococcus pyogenes isolates from throat inf...
Streptococcus pyogenes is responsible for a variety of infectious diseases and immunological complic...
coccus pyogenes), major causative agents of human disease (1), can produce both mild (e.g., pharyngi...
Streptococcal infections are usually treated with beta-lactam antibiotics, but, in case of allergic ...
ABSTRACTAn unusual emm53, T-28/T-non-typeable, iMLSB phenotype clone represented a substantial propo...